Ashwath Jayagopal

Company: Opus Genetics

Job title: Chief Scientific Officer

Seminars:

Establishing a Sustainable Gene Therapy Pipeline for Inherited Retinal Diseases 2:55 pm

Challenges and solutions for creating a sustainable gene therapy pipeline for rare inherited retinal diseases Opus Genetics’ gene therapy portfolio for LCA and other classes of IRDs A Phase 1 trial for LCA5-IRDRead more

day: Day One Track B - Afternoon